Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
BIOGEN IDEC Inc.
(NQ:
BIIB
)
412.79
USD
-3.00 (-0.72%)
Official Closing Price
/ Updated:
8:10 PM EST, Mar 3, 2015
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
1,236,017
Open
415.00
Bid (Size)
400.76 (100)
Ask (Size)
419.87 (100)
Prev. Close
415.79
Today's Range
407.72 - 415.11
52wk Range
272.02 - 412.02
Shares Outstanding
234,614,474
Dividend Yield
N/A
Performance
YTD
+20.70%
+20.70%
1 Month
+17.54%
+17.54%
3 Month
+34.16%
+34.16%
6 Month
+20.33%
+20.33%
1 Year
+20.05%
+20.05%
Top News
More News
Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix® paediatric study
February 27, 2015
from
GlobeNewswire News Releases
Post-Earnings Coverage - Biogen Idec
February 26, 2015
from
PR Newswire
More News
Read More
Top Funds Buying Rackspace, Allergan ogen Idec, Apple
March 03, 2015
category
Mutual Funds
from
Investor's Business Daily - Investing RSS
Why we're cautious about 2015: Germany's Merck
March 03, 2015
category
Merck KGaA
,
Business/Earnings
,
Pfizer Inc
from
CNBC.com News
Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix® paediatric study
February 27, 2015
from
GlobeNewswire Europe
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase 3 ALPROLIX® Pediatric Study
February 27, 2015
from
Business Wire News Releases
25.1% Return Seen to Date on SmarTrend Biogen Idec Call (BIIB)
March 03, 2015
from
Comtex SmarTrend® News Briefs
UPDATE 1-German Merck sees slight gain in 2015 core profit
March 03, 2015
category
companyNews
from
Reuters: Company News
Investors Are Best To Avoid The IShares Nasdaq Biotechnology ETF
March 02, 2015
category
Inv
,
MRK
,
ACAD
, and 11 more.
from
Retirement Investments -- MyPlanIQ » Headline
BRIEF-Swedish Orphan Biovitrum: positive results of phase 3 clinical study of Alprolix
February 27, 2015
category
companyNews
from
Reuters: Company News
Most Bullish Stocks On Twitter Grinding Higher
February 27, 2015
category
Stocks / Equities
from
Blogs - TalkMarkets
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates
Bots go here